Search

Your search keyword '"Defer, G."' showing total 426 results

Search Constraints

Start Over You searched for: Author "Defer, G." Remove constraint Author: "Defer, G."
426 results on '"Defer, G."'

Search Results

1. Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

3. Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI

11. Introduction

12. Signes et symptômes de la sclérose en plaques

13. Diagnostics différentiels de la sclérose en plaques

14. Thérapeutiques et prise en charge de la sclérose en plaques

15. Diagnostic positif de la sclérose en plaques

16. Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

17. Impact of methodological choices in comparative effectiveness studies:application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

18. Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study

19. Impact of education level on multiple sclerosis disability progression in France

20. Influence of socio-economic status on excess mortality of multiple sclerosis

21. Improving the decision to switch from first to second-line therapy in MS: a dynamic scoring system

24. The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies

26. A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort

30. Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI

31. New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions

32. Ear dyskinesia

33. Abstracts

35. 12-2 - Inégalités socio-territoriales et mortalité en excès de patients atteints d'une sclérose en plaques en France : une étude rétrospective-observationnelle

39. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

40. Adverse Drug Reaction Reporting Using a Mobile Device Application by Persons with Multiple Sclerosis: A Cluster Randomized Controlled Trial.

43. NOMAD’ MUS : création d’une cohorte française de neuro-optico-myélite aiguë de Devic et des syndromes neurologiques apparentés

44. Neuromyélite optique de Devic et patients à haut risqué : enquête rétrospective nationale

46. Efficacité comparée du Teriflunomide et du Dimethyl-Fumarate : une étude observationnelle française multicentrique

47. Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study

48. Phase III Dose-Comparison Study of Glatiramer Acetate for Multiple Sclerosis

49. High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study

Catalog

Books, media, physical & digital resources